Independent Director's 2025 Annual Performance Report
To the Shareholders and Shareholder Representatives:
As an independent director of Qianjiang Yong'an Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), I have strictly abided by the "Company Law," "Securities Law," "Administrative Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guide No. 1 - Norms for the Operation of Main Board Listed Companies," and other relevant laws and regulations, as well as the "Articles of Association" and the "Independent Director Work System." I have diligently and faithfully performed my duties, fully exercising my functions as an independent director to effectively protect the legitimate rights and interests of the Company and all shareholders, especially small and medium shareholders.
Due to personal reasons, I resigned on January 14, 2025. I hereby report on my performance during my term in 2025:
I. Basic Information
(I) Work Experience